Stock screenerAll disclosures →
EDGAR →
CHRS
Conviction 28HealthcareScan · Mon, Aug 10, 2026CHRS$1.24-2.36%
ResistanceSupportVol 14Vol MA14 982.17K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.24
Change-2.36%
Gap+3.54%
Rel volume3.76×
Avg volume836.39K
Avg $ vol1.13M
SMA 201.41
SMA 501.45
SMA 2001.59
Price vs 50-14.69%
Price vs 200-21.93%
MA stackbearish
50/200 cross—
Supertrenddown · 1.59
RSI (14)34
MACD hist-0.02
MACD crossbear · 2d
Stoch %K / %D28 / 32
ADX (14)14
+DI / −DI13 / 29
RSI divergence—
MACD divergence—
ATR %+7.95%
ADR %6.07%
52w high2.51
52w low0.8209
From 52w high-50.60%
Above 52w low+51.05%
New 52w highNo
SqueezeOn · 4d
Bollinger width19.19%
%B-0.12
Donchian pos27.66%
Donchian high1.53
Donchian low1.13
AVWAP (52w high)1.74
vs AVWAP high-28.68%
AVWAP (52w low)1.63
vs AVWAP low-24.02%
OBV trendDown
Chaikin MF (20)-0.34
Today vs 20d3.76×
Avg vol (14d)982.17K
Avg vol (20d)836.39K
Avg $ vol (20d)1.13M
Market cap191.58M
RS 3m (vs SPY)-33.54%
RS 6m (vs SPY)-53.35%
RS line new highNo
Trend template2/8
Technical rank8.8
1 week-13.89%
1 month-19.48%
3 months-29.14%
6 months-42.06%
1 year+40.29%
YTD-9.49%
P/E1.14
P/B3.15
P/S—
P/FCF-1.38
EPS1.43
Div yield—
ROE276.18%
ROA87.89%
Debt/Eq1.21
Current1.77
EV/EBITDA-1.01
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth489.41%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value182.32M
Revenue1.4M
Net income-20.63M
Gross profit—
Free cash flow-138.8M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out154.25M
Employees145
ListedThu, Nov 6, 2014
Free float106.86M
Float %71.5%
Short interest23.89M
Days to cover24.4d
Short volume42.4%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank8.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.64
Support1.23
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CHRS
No recent disclosed trades by Congress in CHRS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CHRS · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
O'Donnell-Tormey Jill Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Wahlstrom Mats Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Karachun Rita A Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Wahlstrom Mats Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Newcomer Lee Nisley Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Satvat Ali J. Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Newton Charles W. Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Satvat Ali J. Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Ryan Michael Lee Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Newton Charles W. Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in CHRS · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.